U.S. Cosmetic Market Entry | FDA + MoCRA
Is Your Cosmetic Product Ready for the U.S. Market?
Product listing is only one part of FDA and MoCRA compliance.
Before launch, import or distribution, Sobel helps you understand what may apply to your product, facility, labeling, safety substantiation and U.S. market-entry plan.
- Understand what may apply before entering the U.S. market
- Identify regulatory gaps before listing, launch or distribution
- Get clear next steps from cosmetic compliance specialists
- For brands, manufacturers and exporters with cosmetic products ready or close to launch.
Trusted by companies navigating regulated markets
Is this service for you?
This service is designed for cosmetic brands, manufacturers, distributors and exporters preparing to sell cosmetic products in the United States.
This service is for you if:
- Your cosmetic product is developed or close to launch
- You are preparing to sell, import or distribute cosmetics in the U.S.
- You need clarity before product listing or facility registration
- You want to review labeling, claims or safety substantiation
- You are looking for regulatory guidance, not a low-cost filing service
This is not the right fit for product ideas, formulas, suppliers, courses or private label sourcing.
A listing-only approach can create hidden gaps
Product listing may be required, but it does not replace a complete review of your product, facility, labeling, claims and safety support.
What companies often miss
- FDA and MoCRA applicability review
- Facility registration evaluation
- Safety substantiation records
- Labeling and claims review
- Market-entry documentation
What it can affect
- Launch timing
- Distributor confidence
- Import planning
- Marketplace preparation
- Rework and extra cost
THE SOLUTION
A regulatory readiness review before your U.S. launch
Sobel reviews your product information, company scenario and U.S. market-entry plan to help identify which regulatory requirements may apply before you move forward with listing, registration, labeling, distribution or launch.
- What may apply under FDA and MoCRA
- Whether product listing or facility registration should be considered
- Whether your safety substantiation, labeling and claims need review
- What documentation gaps may need attention before market entry
- What next steps your company should prioritize
What we review before your U.S. launch
A practical review of the main FDA and MoCRA areas that may affect your U.S. cosmetic market entry.
FDA + MoCRA Readiness
Regulatory requirements before U.S. market entry
- FDA and MoCRA applicability review
- Product listing considerations
- Facility registration evaluation
- Responsible person considerations
- Ongoing compliance obligations
- Market-entry regulatory priorities
Product + Documentation Review
Product information, safety support and launch readiness
- Safety substantiation records
- Labeling and claims review
- Ingredient and formula documentation
- Available technical documentation
- Market-entry documentation gaps
- Practical next steps before launch
Reviewed with a regulatory market-entry perspective, not as a basic filing task.
Start with what you already have
You do not need to have every answer before speaking with us. We help identify the next regulatory step based on your current product and market-entry plan.
1
Share your product and U.S. launch plan
Tell us what you have today: product type, company structure, documentation, target channel and expected timeline.
2
We review what may apply
Sobel evaluates the main FDA and MoCRA-related areas that may need attention before market entry.
3
We identify possible gaps
We help identify documentation, labeling, claims or safety support gaps that may affect your next steps.
4
You receive clear next steps
You understand what should be addressed before moving forward with listing, import, distribution or launch.
Why companies work with Sobel
Regulatory support built around cosmetic compliance, market-entry strategy and practical next steps.
Focused on regulated products
Sobel supports companies operating in regulated sectors, including cosmetics, medical devices and IVDs.
Clear assessment before action
We help you understand what may apply before treating listing or registration as isolated tasks.
FDA and MoCRA-oriented guidance
Support for companies preparing to address product listing, facility registration, safety substantiation, labeling and documentation.
Practical next steps
Guidance focused on helping your company move forward with clarity, without unnecessary complexity.
Before you launch, know what may be missing.
Check your FDA and MoCRA readiness before moving forward with listing, import, distribution or marketplace plans.
For companies with cosmetic products ready or close to launch.
Tell Us About Your U.S. Launch Plan
Share what you have today. We’ll help identify the next regulatory step for your cosmetic product.
- Clear next steps
- No obligation
- Initial response from our team
Frequently asked questions
Understand the basics before requesting your review.
In general, cosmetic products and ingredients do not require FDA premarket approval, except for color additives. However, companies are responsible for ensuring that their cosmetic products are safe, properly labeled and compliant with applicable requirements.
Product listing may be required, but it should not be treated as the entire compliance process. Companies may also need to evaluate facility registration, safety substantiation, labeling, claims, responsible person obligations and documentation.
Yes. Sobel can help review your regulatory path, documentation, labeling, claims and applicable requirements before your product moves further into the U.S. market-entry process.
